Neuromuscular stimulation improving blood flow in kidney transplant patient

Understanding Kidney Transplants: A Guide to Lower Limb Edema and Innovative Treatments

Nico Varela in Health & Wellness December 2025 • 4 min read.

"Explore how neuromuscular stimulation offers a promising alternative to traditional compression for managing edema and improving blood flow after kidney transplants."

Kidney transplantation is a life-saving procedure, but it's not without its challenges. Post-operative fluid shifts often lead to significant lower limb edema, causing discomfort and potentially hindering recovery. While intermittent compression (IPC) devices are commonly used, they have limitations. This article explores new advancements in managing this condition.

One promising alternative is the Geko Plus device, an internally powered calf neuromuscular stimulator. This innovative device has shown potential in improving blood flow and reducing edema. We will delve into a recent study that investigates the effectiveness of Geko Plus compared to traditional IPC devices in kidney and pancreas transplant recipients.

Understanding the nuances of post-transplant care is essential for patients and their families. This guide provides insights into the causes and management of lower limb edema, highlighting the benefits of neuromuscular stimulation as a novel treatment option.

Neuromuscular Stimulation: A Breakthrough for Post-Transplant Edema

Neuromuscular stimulation improving blood flow in kidney transplant patient

A recent study compared the effects of neuromuscular stimulation (Geko Plus device) and intermittent compression (IPC) on lower limb edema in kidney and pancreas transplant patients. Thirty patients were randomly assigned to wear either IPC (Group 1) or the Geko Plus device (Group 2) postoperatively until Day 6 after surgery. Researchers measured patient weight, lower leg and thigh circumferences daily, and assessed venous flow using Ultrasound Doppler.

The results revealed significant differences between the two groups:

Calf Circumference: Group 1 (IPC) showed a 7.2% increase in calf circumference, indicating edema, while Group 2 (Geko Plus) showed no change from baseline.
Thigh Circumference: Similar to calf circumference, Group 1 experienced a significant increase in thigh circumference (5.5%), while Group 2 remained stable.
Femoral Vein Flow Velocity: Doppler ultrasound showed a remarkable increase in mean flow velocity in the Geko Plus patients (19 cm/s) compared to the IPC patients (11 cm/s).

These findings suggest that neuromuscular stimulation with the Geko Plus device is more effective in reducing lower limb edema and improving venous flow compared to standard IPC devices. The study also monitored total urine output and serum creatinine levels, with no significant differences between the groups. This indicates that the Geko Plus device does not negatively impact kidney function.

The Future of Edema Management in Kidney Transplant Patients

The study provides compelling evidence for the benefits of neuromuscular stimulation in managing lower limb edema following kidney and pancreas transplantation. The Geko Plus device offers a promising alternative to traditional IPC devices, improving blood flow and reducing edema without negatively impacting kidney function. As research continues, neuromuscular stimulation may become a standard component of post-transplant care, improving patient outcomes and quality of life.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is lower limb edema, and why is it a common problem after kidney transplants?

Lower limb edema refers to the swelling in the legs and feet due to fluid accumulation. After a kidney transplant, this is a frequent issue because of fluid shifts that occur in the post-operative period. The body's fluid balance is disrupted, and the kidneys, which play a key role in regulating fluid, are still adapting. This can lead to swelling, discomfort, and potentially slow the recovery process. Managing this edema is crucial to improve patient outcomes and comfort, and prevent other complications.

How does the Geko Plus device work to address lower limb edema compared to traditional intermittent compression (IPC) devices?

The Geko Plus device, a type of neuromuscular stimulator, works by stimulating the calf muscles to improve blood flow. Unlike intermittent compression (IPC) devices that apply external pressure, the Geko Plus uses electrical impulses to activate the muscles, which then pump blood back towards the heart. In a study, patients using the Geko Plus showed no change in calf circumference, indicating less edema, while those using IPC devices experienced an increase in calf circumference. Moreover, the Geko Plus improved venous flow velocity significantly, suggesting a more effective mechanism for managing edema by actively enhancing circulation.

What were the main findings of the study comparing the Geko Plus device with intermittent compression (IPC) for post-transplant edema?

The study comparing the Geko Plus and IPC devices showed several key differences. Patients using the Geko Plus device had no change in their calf and thigh circumference, indicating no increase in edema, while those using IPC devices experienced increases. Additionally, the Geko Plus group showed a significantly higher femoral vein flow velocity. The study also found no significant differences in urine output or serum creatinine levels between the groups, indicating that the Geko Plus device did not negatively impact kidney function. These findings highlight the superior effectiveness of the Geko Plus device in reducing edema and improving blood flow compared to traditional IPC devices.

Can you explain in detail the impact of the Geko Plus device on blood flow and kidney function in kidney transplant patients?

The Geko Plus device improves blood flow by stimulating the calf muscles, which act as a pump to enhance venous return. The study demonstrated a remarkable increase in femoral vein flow velocity in patients using the Geko Plus, indicating more efficient blood circulation. Regarding kidney function, the study monitored urine output and serum creatinine levels, which are indicators of kidney health. There were no significant differences between patients using the Geko Plus and those using IPC devices, confirming that the Geko Plus device does not negatively affect the function of the newly transplanted kidney. This ensures that the focus on edema management doesn't come at the cost of kidney health.

What are the potential benefits of using neuromuscular stimulation, like the Geko Plus device, in the long term for kidney transplant patients?

In the long term, the use of neuromuscular stimulation such as the Geko Plus device can lead to several benefits for kidney transplant patients. Primarily, by effectively managing lower limb edema, patients can experience reduced discomfort and improved mobility, which enhances their quality of life. Enhanced blood flow, facilitated by the Geko Plus, can also promote better tissue healing and reduce the risk of complications related to poor circulation. This innovative approach potentially leads to fewer hospital readmissions and a smoother recovery process, ultimately helping patients maintain their overall health and well-being post-transplant, allowing them to live a more active and fulfilling life.